Fireside Chat: Aligning Route & Frequency of Administration with Real-World Patient Needs & Treatment Goals

2:40 pm - Wednesday 9th December 2026

  • How do patient preferences differ across daily oral, weekly injectable, monthly injectable, and long acting therapies, and what factors most influence modality selection?
  • How should developers balance the convenience of long-acting treatments against the safety and practical considerations associated with pregnancy, adverse events, surgical procedures, and changing patient circumstances?
  • What is the optimal dosing frequency, to maximize adherence and persistence while sufficient flexibility for dose adjustments, treatment interruptions and treatment discontinuation when needed?

Speakers:

Founder & CEO
Incregen Therapeutics
Chief Executive Officer
Vivani
Executive Director, CVRM
Genentech